XFOR

4.04

1.00% 0.04

Dopo l'orario di chiusura: 4.12 0.08 +1.98%

X 4 Pharmaceuticals Inc (XFOR)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Forum Previsione Frazionamento azionario

Precedente Chiudi:

$4.00

Aprire:

$3.97

Volume 24 ore:

352.42K

Relative Volume:

0.36

Capitalizzazione di mercato:

$353.24M

Reddito:

$32.77M

Utile/perdita netta:

$-101.98M

Rapporto P/E:

-0.4204

EPS:

-9.6101

Flusso di cassa netto:

$-112.43M

1 W Prestazione:

+1.00%

1M Prestazione:

+5.21%

6M Prestazione:

+142.64%

1 anno Prestazione:

-78.84%

Intervallo 1D:

$3.86

$4.04

Intervallo di 1 settimana:

$3.74

$4.08

Portata 52W:

$1.35

$24.43

X 4 Pharmaceuticals Inc Stock (XFOR) Company Profile

Nome

X 4 Pharmaceuticals Inc

Settore

Healthcare (1113)

Industria

Biotechnology (621)

Telefono

857-529-8300

Indirizzo

61 NORTH BEACON STREET, BOSTON, MA

Dipendente

143

Cinguettio

@x4pharma

Prossima data di guadagno

2025-03-25

Ultimi documenti SEC

XFOR's Discussions on Twitter

Confronta XFOR con altri titoli

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
XFOR X 4 Pharmaceuticals Inc	4.04	349.75M	32.77M	-101.98M	-112.43M	-9.6101
VRTX Vertex Pharmaceuticals Inc	469.68	122.84B	11.74B	3.68B	3.34B	14.19
REGN Regeneron Pharmaceuticals Inc	801.01	85.37B	14.25B	4.58B	3.88B	41.77
ALNY Alnylam Pharmaceuticals Inc	399.40	55.82B	3.21B	43.57M	221.36M	0.2405
ARGX Argen X Se Adr	795.57	50.67B	3.06B	1.28B	447.35M	19.67
INSM Insmed Inc	170.27	37.54B	447.02M	-1.18B	-906.14M	-6.1812

X 4 Pharmaceuticals Inc Stock (XFOR) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2025-12-05	Ripresa	Stifel	Buy
2023-12-12	Downgrade	B. Riley Securities	Buy → Neutral
2023-08-30	Ripresa	B. Riley Securities	Buy
2022-12-22	Iniziato	Cantor Fitzgerald	Overweight
2022-12-12	Iniziato	Piper Sandler	Overweight
2019-12-23	Iniziato	Oppenheimer	Outperform
2019-12-18	Iniziato	ROTH Capital	Buy
2019-12-09	Aggiornamento	Citigroup	Neutral → Buy
2019-12-05	Iniziato	B. Riley FBR	Buy
2019-06-07	Iniziato	Stifel	Buy
2019-06-05	Iniziato	Cowen	Outperform

Mostra tutto

X 4 Pharmaceuticals Inc Borsa (XFOR) Ultime notizie

Jan 08, 2026

Why X4 Pharmaceuticals Inc. stock remains resilient2025 Investor Takeaways & High Yield Stock Recommendations - ulpravda.ru

Jan 08, 2026

Why X4 Pharmaceuticals Inc. (48Q0) stock fits value portfoliosJuly 2025 Breakouts & Free Real-Time Market Sentiment Alerts - ulpravda.ru

Jan 08, 2026

Revenues Tell The Story For Phathom Pharmaceuticals, Inc. (NASDAQ:PHAT) As Its Stock Soars 27% - simplywall.st

Jan 08, 2026

Jan 07, 2026

Can X4 Pharmaceuticals Inc. stock deliver sustainable ROEInsider Selling Patterns & Investment Risk Management Tips - ulpravda.ru

Jan 07, 2026

X4 Pharmaceuticals, Inc. (NASDAQ:XFOR) Given Consensus Rating of “Hold” by Analysts - Defense World

Jan 07, 2026

Jan 06, 2026

Europe reviews first nose-spray patients could use for sudden PSVT - Stock Titan

Jan 06, 2026

X4 Pharmaceuticals, Inc. (NASDAQ:XFOR) Given Consensus Rating of "Hold" by Analysts - MarketBeat

Jan 06, 2026

What drives X4 Pharmaceuticals Inc 48Q0 stock priceAnalyst Upgrades & Free Powerful Profit Generation - earlytimes.in

Jan 06, 2026

Jan 05, 2026

Torrent Pharma board gives nod to Rs 12,500-crore bond issue - TradingView — Track All Markets

Jan 05, 2026

Jan 04, 2026

Phathom Pharmaceuticals, Inc. (NASDAQ:PHAT) Given Consensus Recommendation of "Moderate Buy" by Analysts - MarketBeat

Jan 04, 2026

Jan 02, 2026

Xeris Pharmaceuticals Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) - Business Wire

Jan 02, 2026

Layoff Tracker: Nido Will Close Following Lead Candidate’s Disappointing Phase II Results - BioSpace

Jan 02, 2026

Jan 01, 2026

What drives X4 Pharmaceuticals Inc stock pricePrice Momentum Alerts & Free Trading Signals to Sharpen Your Edge - earlytimes.in

Jan 01, 2026

4,485 Shares in Madrigal Pharmaceuticals, Inc. $MDGL Bought by Calamos Advisors LLC - MarketBeat

Jan 01, 2026

Dec 31, 2025

More than 4,600 Massachusetts biotech workers lost jobs in 2025 as industry contracts - The Business Journals

Dec 31, 2025

Short Interest in X4 Pharmaceuticals, Inc. (NASDAQ:XFOR) Grows By 27.1% - Defense World

Dec 31, 2025

Dec 30, 2025

Vanda Pharmaceuticals Announces FDA Approval of NEREUS™ (tradipitant) for the Prevention of Vomiting Induced by Motion: A Historic Scientific Milestone in the Prevention of Motion Sickness - PR Newswire

Dec 30, 2025

Dec 29, 2025

Short Covering: Why X4 Pharmaceuticals Inc 48Q0 stock is a strong buy callJuly 2025 Analyst Calls & Risk Controlled Daily Trade Plans - moha.gov.vn

Dec 29, 2025

X4 Pharmaceuticals, Inc. (NASDAQ:XFOR) Q4 2024 Earnings Call Transcript - MSN

Dec 29, 2025

Alnylam Pharmaceuticals, Inc. $ALNY Shares Bought by Cwm LLC - MarketBeat

Dec 29, 2025

Dec 28, 2025

ANI Pharmaceuticals, Inc. $ANIP Shares Sold by Rice Hall James & Associates LLC - MarketBeat

Dec 28, 2025

Dec 27, 2025

174,077 Shares in Crinetics Pharmaceuticals, Inc. $CRNX Purchased by Rice Hall James & Associates LLC - MarketBeat

Dec 27, 2025

Corvus Pharmaceuticals, Inc. (NASDAQ:CRVS) Given Average Rating of "Moderate Buy" by Brokerages - MarketBeat

Dec 27, 2025

Dec 24, 2025

Should You Buy X4 Pharmaceuticals (XFOR) After Golden Cross? - Finviz

Dec 24, 2025

X4 Pharmaceuticals, Inc.'s (NASDAQ:XFOR) Shares May Have Run Too Fast Too Soon - simplywall.st

Dec 24, 2025

Primary Endpoint Successfully Achieved in Lexaria’s Phase 1b Study GLP-1-H24-4 - York Dispatch

Dec 24, 2025

Dec 22, 2025

IndMoney and Federal Bank Savings AccountBull Market Opportunities & Subscribe for Free Weekly Winners - Bollywood Helpline

Dec 22, 2025

Dec 20, 2025

Will X4 Pharmaceuticals Inc. (48Q0) stock boost dividends further2025 Price Targets & Long Hold Capital Preservation Plans - Улправда

Dec 20, 2025

Will X4 Pharmaceuticals Inc. stock continue upward momentumEarnings Trend Report & Safe Entry Trade Signal Reports - Улправда

Dec 20, 2025

Regeneron Pharmaceuticals, Inc. $REGN Shares Sold by Thrivent Financial for Lutherans - MarketBeat

Dec 20, 2025

Dec 19, 2025

Will X4 Pharmaceuticals Inc. stock deliver long term returns2025 Price Targets & Free Community Supported Trade Ideas - Улправда

Dec 19, 2025

Can X4 Pharmaceuticals Inc. stock sustain institutional interestMarket Performance Report & Risk Controlled Stock Pick Alerts - Улправда

Dec 19, 2025

Can X4 Pharmaceuticals Inc. stock sustain market leadership2025 Biggest Moves & Advanced Swing Trade Entry Alerts - DonanımHaber

Dec 19, 2025

Day Trade: Can X4 Pharmaceuticals Inc. stock sustain market leadershipQuarterly Market Summary & Daily Stock Momentum Reports - DonanımHaber

Dec 19, 2025

Institution Moves: Can X4 Pharmaceuticals Inc. stock outperform in 2025 bull marketMarket Growth Report & Risk Managed Investment Strategies - DonanımHaber

Dec 19, 2025

Can X4 Pharmaceuticals Inc. stock outperform in 2025 bull marketTrade Entry Report & Capital Efficiency Focused Strategies - DonanımHaber

Dec 19, 2025

Pfizer Inc. | Pharmaceuticals, Vaccines & Company History | Britannica Money - Britannica

Dec 19, 2025

Dec 18, 2025

Merger Talk: Is X4 Pharmaceuticals Inc. stock supported by strong fundamentals2025 Market Trends & Reliable Price Action Trade Plans - Улправда

Dec 18, 2025

Dec 17, 2025

• Position Sizing: Never all in — always size by riskInflation Impact on Stocks & Explosive Capital Gains - Bollywood Helpline

Dec 17, 2025

InMed Pharmaceuticals (INM) reports senior VP employee option expiration - Stock Titan

Dec 17, 2025

Dec 15, 2025

Weekly Analysts’ Ratings Changes for X4 Pharmaceuticals (XFOR) - Defense World

Dec 15, 2025

Dec 14, 2025

Aug Opening: Will X4 Pharmaceuticals Inc. stock deliver long term returns2025 Technical Overview & Verified Chart Pattern Trade Signals - moha.gov.vn

Dec 14, 2025

Dec 13, 2025

Bain Capital Life Sciences Investors LLC Sells 16,351,925 Shares of X4 Pharmaceuticals, Inc. $XFOR - MarketBeat

Dec 13, 2025